Featured Research

from universities, journals, and other organizations

Penn Researchers Find Chemoembolization Effective For Liver Tumors

Date:
March 26, 1999
Source:
University Of Pennsylvania Medical Center
Summary:
More than 150,000 new cases of colon cancer are diagnosed each year, and, for half of these patients, the disease spreads to the liver. A Phase-II study performed by a team of researchers at the University of Pennsylvania Medical Center has found that a minimally invasive technique known as chemoembolization may double the survival time of adult patients with colon cancer that has spread to the liver.

Chemotherapy Delivered Directly to Liver Tumors Doubles Life Expectancy

(Philadelphia, PA) -- More than 150,000 new cases of colon cancer are diagnosed each year, and, for half of these patients, the disease spreads to the liver. A Phase-II study performed by a team of researchers at the University of Pennsylvania Medical Center has found that a minimally invasive technique known as chemoembolization may double the survival time of adult patients with colon cancer that has spread to the liver. Michael C. Soulen, MD, associate professor of radiology at Penn and senior author of the study, will present these findings at the 24th Annual Scientific Meeting of the Society of Cardiovascular & Interventional Radiology (SCVIR) on Wednesday, March 24, in Orlando, Florida.

Systemic chemotherapy delivers cancer-killing medication into the bloodstream where it travels throughout the body and eventually reaches the tumor. In contrast, chemoembolization works by delivering chemotherapy directly to cancerous cells with the use of a non-surgical, interventional catheterization technique. This technique also involves the infusion of tiny particles that cut off the blood supply to the tumor, thus inhibiting cancer-cell growth. Colon cancer that has metastasized, or spread, can be managed with chemoembolization when systemic chemotherapy has failed. "Chemoembolization hones in on the cancerous cells that have spread to the liver and avoids exposing the rest of the body to chemotherapy's toxic effects," explains Dr. Soulen. "This technique is not a cure, but it can extend patients' lives and preserve their quality of life."

In this study, 51 patients whose colon cancer had metastasized to the liver were treated with chemoembolization. Eighty-six percent (86%), or 44 of the patients, survived one year after treatment. The patients in this study survived an average of two years. Typically, less than half of liver cancer patients survive one year after undergoing systemic chemotherapy.

Chemoembolization is performed while the patient is under conscious sedation, and is administered by an interventional radiologist. The procedure involves making a small needle puncture in the patient's groin and inserting a catheter, or tiny tube, into the liver's hepatic artery. Using a moving X-Ray, the arteries to the liver are identified and three chemotherapy drugs are delivered directly to the hepatic artery leading to the tumor -- thus sparing healthier liver tissue. The hepatic artery is then blocked off, or embolized, with a mixture of oil and tiny particles. This technique deprives the tumor of fortifying oxygen and nutrients, while saturating the tumor with high doses of medication. Chemoembolization is effective without damaging the liver because the hepatic artery is central to the tumor's survival, however it provides only twenty-five percent (25%) of the liver's blood supply. The liver is unique in that it has two blood supplies -- a hepatic artery as well as a large portal vein that furnishes ample blood flow on its own.

The chemoembolization procedure is approximately three hours in length, and involves an overnight hospital stay. It is performed repeatedly on a monthly basis, with an average treatment regimen of approximately three sessions.

"With chemoembolization we can offer a less taxing and effective treatment for liver cancer," said Dr. Soulen. "Although not curative, it can extend and preserve a more normal life for the patient by minimizing the cancer and its effects."


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Penn Researchers Find Chemoembolization Effective For Liver Tumors." ScienceDaily. ScienceDaily, 26 March 1999. <www.sciencedaily.com/releases/1999/03/990326062102.htm>.
University Of Pennsylvania Medical Center. (1999, March 26). Penn Researchers Find Chemoembolization Effective For Liver Tumors. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/1999/03/990326062102.htm
University Of Pennsylvania Medical Center. "Penn Researchers Find Chemoembolization Effective For Liver Tumors." ScienceDaily. www.sciencedaily.com/releases/1999/03/990326062102.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins